Table 2. The Correlation between Liver Fibrosis Stages and the Other Clinical Characteristics.
| r | P | |
|---|---|---|
| Sex* | 0.136 | |
| Age | 0.368 | < 0.001 |
| PT-INR | 0.018 | 0.793 |
| Platelet count (x 109) | 0.021 | 0.801 |
| Bile acid (μmol/L) | 0.140 | 0.049 |
| Total bilirubin (μmol/L) | 0.242 | < 0.001 |
| Direct bilirubin (μmol/L) | 0.204 | 0.003 |
| Indirect bilirubin (μmol/L) | 0.167 | 0.014 |
| Albumin (g/L) | -0.040 | 0.569 |
| Alanine aminotransferase (U/L) | 0.108 | 0.113 |
| Aspartate aminotransferase (U/L) | 0.202 | 0.003 |
| Ƴ-glutamyltransferase (U/L) | 0.319 | < 0.001 |
| APRi | 0.179 | 0.008 |
| 2D SWE | 0.786 | < 0.001 |
| Serum fibrotic biomarkers | n = 163 | |
| Fibronectin (mg/L) | 0.251 | 0.001 |
| Hyaluronic acid (ng/mL) | 0.207 | 0.008 |
| Laminin (ng/mL) | -0.056 | 0.475 |
| Procollagen type III amino-terminal peptide (ng/mL) | -0.083 | 0.293 |
| Type IV collagen (ng/mL) | 0.241 | 0.002 |
*The effect of sex on 2D SWE values was assessed with the Mann-Whitney U test. APRi = aspartate aminotransferase to platelet ratio index, PT-INR = prothrombin time-international normalized ratio, SWE = shear wave elastography, 2D = two-dimensional